Skip to search formSkip to main contentSkip to account menu

HPA 23

Known as: HPA-23, Heteropolyanion-23 
National Institutes of Health

Related topics

Related topics

1 relation
5-tungsto-2-antimoniate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection
SummaryThe effects of up to 12 daily doses of HPA-23 (ammonium 5-tungsto-2-antimoniate) on scrapie were studied using five… 
1994
1994
Use of a flavivirus RNA-dependent RNA polymerase assay to investigate the antiviral activity of selected compounds.
1990
1990
Subcellular localization of HPA-23 in different rat organs: electron microprobe study.
  • J. BerryP. Gallé
  • Experimental and molecular pathology (Print)
  • 1990
  • Corpus ID: 12711008
1989
1989
Effects of suramin, HPA-23 and 3'-azidothymidine triphosphate on the reverse transcriptase of bovine leukaemia virus.
We used purified bovine leukaemia virus (BLV) to test the inhibitory effects of suramin, HPA-23, and 3'-azidothymidine… 
Highly Cited
1988
Highly Cited
1988
Clinical trial of tolerance of HPA-23 in patients with acquired immune deficiency syndrome
An open-label, multicenter clinical trial assessed the tolerance of HPA-23 (ammonium-21-tungsto-9-antimoniate) in patients with… 
Review
1988
Review
1988
Antiviral drugs other than zidovudine and immunomodulating therapies in human immunodeficiency virus infection. An overview.
Although the management of patients with human immunodeficiency virus infections has focused on the treatment of opportunistic… 
Highly Cited
1986
Highly Cited
1986
Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T‐cell lymphotropic virus (HTLV‐III)/lymphadenopathy‐associated virus (LAV)
Suramin and various other selected compounds were evaluated for their in vitro inhibitory effects on the infectivity and… 
1986
1986
Efficacy of heteropolyanions against rabies virus infection in mice
1985
1985
AIDS therapy: new push for clinical trials.
There is clearly a long way to go before an effective therapy is developed for acquired immunodeficiency syndrome (AIDS). However… 
1984
1984
Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine.
The polyoxotungstate HPA-23 was found to exert a differential effect on the induction of Epstein-Barr virus early antigen in Raji… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)